We would like to take great pleasure in inviting you to participate in
the 3rd Tehran Hepatitis Congress hosted by Baqiyatallah Research Center
for Gastroenterology and Liver Disease, Health Policy Research Center,
Shiraz University of Medical Sciences, and the Iranian Hepatitis
Network, which will take place in Tehran, Iran, October 6-9, 2010 (Three
days in Tehran and One day in Shiraz!). The following centers will
collaborate in organizing the congress:

· Research Center for Gastroenterology and Liver Diseases
(RCGLD), Shahid Beheshti University of Medical Sciences

· Digestive Disease Research Center (DDRC), Tehran University of
Medical Sciences

· Liver and Gastrointestinal Diseases Research Center (LGDRC),
Tabriz University of Medical Sciences

· Gastrointestinal and Liver Diseases Research Center (GLDRC),
Guilan University of Medical Sciences

· Schering-Plough Pharmaceutical Company

· Roche Pharmaceutical Company


This meeting will present the ‘state of the art’, and the ‘cutting
edge’, of viral hepatitis to a large audience of specialists active in
these fields, particularly those involved in basic research and in the
clinical care of patients with liver disease and hepatitis B and C. Your
contributions will add meaningfully to the scientific value of our
meeting.

The Iran Hepatitis Network is a complex of national research centers
organized to propose and coordinate research projects in the field of
hepatitis and other liver diseases. It was founded in 2000 by some of
the most eminent hepatologists in the country. The main goal of the Iran
Hepatitis Network is to assist these national research, diagnostic and
treatment centers in drawing closer, by using all of the potential of
these various centers for common research projects; to motivate team
work in the country; to provide a national database for researchers and
research centers; to maintain priorities in hepatologic studies in Iran,
and also to hold and support high-level international hepatology
seminars in the country.

You are invited to submit the abstract of your paper through the
congress website at www.thc3.ir <http://www.thc3.ir/> . Your abstract
will be peer-reviewed by our scientific committee and accepted either
for oral presentation or as a representative poster according to their
decision. Authors of abstracts accepted for presentation will receive
notification and information regarding their presentation by August 1,
2010.
We are looking forward to enjoying with you the strong and attractive
scientific program which will include every aspect and all recent
developments in all disciplines of viral hepatitis. The preliminary
scientific program is available at:
http://seminars.brcgl.com/2/timetable.php
<http://seminars.brcgl.com/2/timetable.php> .